Stimuvax cancer vaccine goes to Phase III trial

(Reuters) UPDATED 2009-06-22

Drugmaker Merck says their experimental vaccine Stimuvax has started a Phase III clinical trial for breast cancer and lung cancer. The drug has been shown to help prime a patient's immune system to recognize and kill cancer cells. The newest study will be conducted on patients who have advanced, inoperable breast cancer, and patients who have advanced, inoperable lung cancer, researchers say. Read full story >

See all Breast Cancer News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyBreastCancerNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyBreastCancerNetwork.com

Stimuvax cancer vaccine goes to Phase III trial

People who read this also read...

What the community is saying...

Day by day

Rachel